Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients
Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
This clinical trial aims to investigate whether the low treatment intensity (12 mL/kg/hr,
low-dose hemodialysis/filtration) or the medium treatment intensity (25 mL/kg/hr,
standard-dose hemodialysis/filtration) is more effective and safer for continuous renal
replacement therapy in critically ill patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jikei University School of Medicine
Collaborators:
Jichi Medical University Keio University Tsuchiura Kyodo General Hospital University of Fukui Wakayama Medical University